Actually, I think CaptBeer should send the letter to Amarin so that they can use it as a template to provide to any patient that contacts them about being denied Vascepa.
Salute that Sarissa (I assume) - dont take any chances here (put a floor under SP at $1.20). --------------------------------------------
Looking at all the positive indications lately - it does seen that there are 'deliberate' forces trying to interfere (short pressure).
I have read somewhere that GS has a memory like an elefant - when it comes to losses. And JT raising 400 mill - $18 a share - might still be what make them put a 'sell' sign on Amarin shares 'even now' - after a great Q4 2023.
News 
Market Data 
Discover 
